mRNA Vaccine Delivery via Intramuscular Electroporation Induces Protective Antiviral Immune Responses in Mice
Open Access
- 17 April 2025
- journal article
- research article
- Published by MDPI AG in Applied Sciences
- Vol. 15 (8) , 4428
Abstract
Messenger RNA (mRNA) vaccines have exhibited promising potential for infectious disease prevention. Although various delivery methods have been explored, the use of electroporation (EP) for the delivery of naked mRNA has received relatively less attention. In this study, we used mouse models to investigate whether naked mRNA vaccine delivery via intramuscular EP (IM-EP) elicits a protective immune response against lethal viral infection. To achieve this, we injected C57BL/6 mice with naked mRNA encoding the SARS-CoV-2 mRNA vaccine via IM-EP and evaluated the resulting immune responses. IM-EP-mediated delivery of the mRNA vaccine induced robust humoral and cellular immune responses, characterized by elevated SARS-CoV-2 receptor-binding domain (RBD)-specific IgG antibodies, enhanced IFN-γ production by CD8+ T cells, and upregulated cytokine expression in the muscle and lymph nodes. Using the K18-hACE2 mouse model, we revealed that IM-EP-mediated delivery of the naked mRNA vaccine effectively protected mice from lethal SARS-CoV-2 infection. Overall, our findings suggest that the delivery of naked mRNA via IM-EP can be an effective strategy for preventing infectious diseases.Keywords
Funding Information
- Ministry of Health and Welfare, Republic of Korea (RS-2022-KH128441, 20019452, 22213MFDS421)
- Ministry of Trade, Industry and Energy (MOTIE, Korea) (RS-2022-KH128441, 20019452, 22213MFDS421)
- Ministry of Food and Drug Safety (RS-2022-KH128441, 20019452, 22213MFDS421)
This publication has 42 references indexed in Scilit:
- Myocarditis following COVID ‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesEuropean Journal of Heart Failure, 2022
- The mRNA-LNP platform's lipid nanoparticle component used in preclinical vaccine studies is highly inflammatoryiScience, 2021
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stabilityInternational Journal of Pharmaceutics, 2021
- Wet-cupping induces anti-inflammatory action in response to vigorous exercise among martial arts athletes: A pilot studyComplementary Therapies in Medicine, 2021
- DNA vaccines: prime time is nowCurrent Opinion in Immunology, 2020
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA VaccinesMolecular Therapy Nucleic Acids, 2019
- Intramuscular DNA immunization with in vivo electroporation induces antigen-specific cellular and humoral immune responses in both systemic and gut-mucosal compartmentsVaccine, 2012
- A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscleVaccine, 2011
- Immunotherapy of Cancer with Dendritic Cells Loaded with Tumor Antigens and Activated Through mRNA Electroporation2010
- In vitro and in vivo electric field-mediated permeabilization, gene transfer, and expressionMethods, 2004